Production of gamma immune protein capsules
An immunoglobulin and capsule technology, which is applied in the directions of capsule delivery, antiviral agents, and drug combination, can solve the problems of large consumption of organic solvents and chemical reagents, lengthy preparation of immunoglobulins, inconvenient recovery of purified organic solvents, etc. Avoid dust flying, facilitate mechanized or automated production, and be suitable for continuous large-scale production
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0027] (1) Source and collection of blood:
[0028] Fresh pig blood or goose blood produced by fixed-point slaughter (all slaughtered pigs have passed strict quarantine inspection).
[0029] The animal blood is firstly collected by vacuum and then flowed through pipelines into a closed and constant temperature container (with anticoagulant added in advance) for inspection. The blood and dirty blood are discarded, and then transported to the separation workshop through a refrigerated device.
[0030] (2) Separation:
[0031] The blood is input into the continuous separator through the pipeline, and the serum is separated and collected in the storage tank.
[0032] (3) Dehydration:
[0033] The serum stored in the storage tank is fed into a hollow fiber ultrafiltration device with a molecular weight of 100,000 through a peristaltic pump to filter out 20% of the water in the plasma.
[0034] (4) Salting out:
[0035] Put the above water-filtered serum into a stainless steel r...
Embodiment 2
[0045] Technical process (1)-(8) is the same as embodiment 1, except that steps (6) and (7) adopt the following material proportioning, the material proportioning of all the other steps is the same as embodiment 1.
[0046] Step (6) adds stabilizer:
[0047] Then in the above ultrafiltrate by 0.1% by weight of the filtrate, add a polysaccharide mixture with a weight ratio of 1: 15 and gelatin to mix as a stabilizer, wherein the polysaccharide mixture is sucrose, maltose, lentinan, astragalus polysaccharide in a weight ratio of 1: 05 : 0.2: 0.1 uniformly mixed. To ensure that the product is not damaged during the drying process, the activity can reach more than 80%.
[0048] Step (8) disinfection and sterilization:
[0049] Gamma immunoglobulin, lentinan and astragalus polysaccharide are uniformly mixed in a ratio of 1:0.2:0.4 by weight, irradiated with gamma ray to make it reach the hygienic standard, and then made into capsules.
Embodiment 3
[0051] Technical process (1)-(8) is the same as embodiment 1, except that steps (6) and (7) adopt the following material proportioning, the material proportioning of all the other steps is the same as embodiment 1.
[0052] Step (6) adds stabilizer:
[0053] Then in the above ultrafiltrate by 0.5% by weight of the filtrate, add a polysaccharide mixture with a weight ratio of 1: 3 and mix it with gelatin as a stabilizer, wherein the polysaccharide mixture is sucrose, maltose, lentinan, and astragalus polysaccharide in a weight ratio of 1: 1.5 : 1: 0.5 evenly mixed. To ensure that the product is not damaged during the drying process, the activity can reach more than 80%.
[0054] Step (8) disinfection and sterilization:
[0055] Gamma immunoglobulin, lentinan and astragalus polysaccharide are uniformly mixed in a ratio of 1:0.6:0.8 in parts by weight, irradiated with gamma ray to make it reach the hygienic standard, and then made into capsules.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 